• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内科医生的遗传学。

Genetics for the general internist.

机构信息

Department of Medicine, University of Arizona, Tucson, 85724, USA.

出版信息

Am J Med. 2012 Jan;125(1):7-13. doi: 10.1016/j.amjmed.2011.07.034. Epub 2011 Nov 11.

DOI:10.1016/j.amjmed.2011.07.034
PMID:22079017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3246053/
Abstract

The internist's goal is to determine a patient's disease risk and to implement preventative interventions. Genetic evaluation is a powerful risk assessment tool, and new interventions target previously untreatable genetic disorders. The purpose of this review is to educate the general internist about common genetic conditions affecting adult patients, with special emphasis on diagnoses with an effective intervention, including hereditary cancer syndromes and cardiovascular disorders. Basic tenets of genetic counseling, complex genetic disease, and management of adults with genetic diagnoses also are discussed.

摘要

内科医生的目标是确定患者的疾病风险,并实施预防干预措施。遗传评估是一种强大的风险评估工具,新的干预措施针对以前无法治疗的遗传疾病。本综述的目的是教育普通内科医生有关影响成年患者的常见遗传疾病,特别强调有有效干预措施的诊断,包括遗传性癌症综合征和心血管疾病。还讨论了遗传咨询的基本原则、复杂的遗传疾病以及对有遗传诊断的成年人的管理。

相似文献

1
Genetics for the general internist.内科医生的遗传学。
Am J Med. 2012 Jan;125(1):7-13. doi: 10.1016/j.amjmed.2011.07.034. Epub 2011 Nov 11.
2
Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.遗传性癌症综合征与风险评估:ACOG 委员会意见摘要,编号 793。
Obstet Gynecol. 2019 Dec;134(6):1366-1367. doi: 10.1097/AOG.0000000000003563.
3
[Interest of an internist's consultation in uveitis. Comparative study in 66 cases].[内科医生会诊对葡萄膜炎的意义。66例对比研究]
Rev Med Interne. 2006 Sep;27(9):671-8. doi: 10.1016/j.revmed.2006.05.014. Epub 2006 Jun 28.
4
Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.级联遗传检测在遗传性癌症综合征中的应用:障碍与突破的综述。
Fam Cancer. 2024 Jun;23(2):111-120. doi: 10.1007/s10689-024-00373-4. Epub 2024 Mar 26.
5
Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.遗传性癌症综合征与风险评估:ACOG 委员会意见,第 793 号。
Obstet Gynecol. 2019 Dec;134(6):e143-e149. doi: 10.1097/AOG.0000000000003562.
6
Genetic testing by cancer site: ovary.按癌症部位进行的基因检测:卵巢。
Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2.
7
Identifying hereditary cancer: genetic counseling and cancer risk assessment.识别遗传性癌症:遗传咨询与癌症风险评估。
Curr Probl Cancer. 2014 Nov-Dec;38(6):216-25. doi: 10.1016/j.currproblcancer.2014.10.002. Epub 2014 Oct 29.
8
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.遗传性结直肠癌综合征:分子遗传学、遗传咨询、诊断与管理
Fam Cancer. 2008;7(1):27-39. doi: 10.1007/s10689-007-9165-5. Epub 2007 Nov 13.
9
Genetic risk assessment, counseling and testing.遗传风险评估、咨询与检测。
Surg Oncol Clin N Am. 2009 Jan;18(1):19-38, vii. doi: 10.1016/j.soc.2008.08.004.
10
Internal medicine in the current health care environment: a need for reaffirmation.当前医疗保健环境下的内科医学:需要重新确认。
Ann Intern Med. 1998 May 15;128(10):857-62. doi: 10.7326/0003-4819-128-10-199805150-00010.

本文引用的文献

1
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.筛查对卵巢癌死亡率的影响:前列腺癌、肺癌、结直肠癌和卵巢癌(PLCO)癌症筛查随机对照试验。
JAMA. 2011 Jun 8;305(22):2295-303. doi: 10.1001/jama.2011.766.
2
Exemestane for breast-cancer prevention in postmenopausal women.依西美坦用于绝经后妇女的乳腺癌预防。
N Engl J Med. 2011 Jun 23;364(25):2381-91. doi: 10.1056/NEJMoa1103507. Epub 2011 Jun 4.
3
The application of massively parallel sequencing technologies in diagnostics.大规模平行测序技术在诊断中的应用。
F1000 Biol Rep. 2010 Aug 9;2:59. doi: 10.3410/B2-59.
4
Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.EGAPP 工作组的建议:对有特发性静脉血栓栓塞史及其成年亲属的成年人进行因子 V 莱顿(R506Q)和凝血酶原(20210G>A)突变的常规检测。
Genet Med. 2011 Jan;13(1):67-76. doi: 10.1097/GIM.0b013e3181fbe46f.
5
Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.使用基因组捕获和大规模平行测序检测乳腺癌和卵巢癌的遗传突变。
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12629-33. doi: 10.1073/pnas.1007983107. Epub 2010 Jun 28.
6
The revised Ghent nosology for the Marfan syndrome.修订版马凡综合征根特分类法。
J Med Genet. 2010 Jul;47(7):476-85. doi: 10.1136/jmg.2009.072785.
7
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性的基因和基因组检测
J Clin Oncol. 2010 Feb 10;28(5):893-901. doi: 10.1200/JCO.2009.27.0660. Epub 2010 Jan 11.
8
Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.遗传性通道病的机制和临床处理:长 QT 综合征、Brugada 综合征、儿茶酚胺多形性室性心动过速和短 QT 综合征。
Heart Rhythm. 2009 Aug;6(8 Suppl):S51-5. doi: 10.1016/j.hrthm.2009.02.009. Epub 2009 Feb 12.
9
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.美国临床肿瘤学会关于使用包括他莫昔芬、雷洛昔芬和芳香化酶抑制在内的药物干预措施降低乳腺癌风险的临床实践指南更新。
J Clin Oncol. 2009 Jul 1;27(19):3235-58. doi: 10.1200/JCO.2008.20.5179. Epub 2009 May 26.
10
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.对BRCA1或BRCA2基因突变携带者行降低风险的输卵管卵巢切除术相关风险降低估计值的荟萃分析。
J Natl Cancer Inst. 2009 Jan 21;101(2):80-7. doi: 10.1093/jnci/djn442. Epub 2009 Jan 13.